Anesthesia

Aidéo Technologies and Shareable Forms Announce Joint Partnership to Align Complimentary Technologies and Streamline Revenue Cycle Processes For Healthcare Providers

Retrieved on: 
Tuesday, March 12, 2024
IPad, Machine learning, Programmer, Health, Natural language, Partnership, Anesthesia, PALM, NLP, Artificial intelligence, AI, Workflow, CPT, Gemini, Multimedia, Generative, Medical device

Shareable Forms can now offer customers the ability to streamline the mid-revenue cycle process with AI-driven medical coding productivity tools using discreet data captured by the Shareable Forms application.

Key Points: 
  • Shareable Forms can now offer customers the ability to streamline the mid-revenue cycle process with AI-driven medical coding productivity tools using discreet data captured by the Shareable Forms application.
  • Shareable Forms assists healthcare providers by eliminating paper forms in the practice setting and providing a customizable framework for making the data those forms contain available electronically.
  • "We're excited about extending the capabilities we can offer to our customers by integrating with Aideo's medical coding solutions," said Holly O'Hare, CEO of Shareable Forms.
  • Aidéo Technologies is a leading provider of AI-powered medical coding productivity solutions to the revenue cycle management industry.

Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care

Retrieved on: 
Monday, March 11, 2024
Hospital, Neurology, Radiation, Apollo, Health, Anesthesia, Patient, Neoplasm, Stroke, Stereotactic surgery, Quality of life, Cancer, Apollo Hospitals, Medical imaging

ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.

Key Points: 
  • ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.
  • Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group said, "For four decades, Apollo Hospitals has pioneered healthcare, advancing exceptional care.
  • We pledge to democratize technology, making it accessible to all citizens and global communities, elevating standards of brain tumor treatment and ensuring better quality of life.
  • The Apollo Institute of Neurosciences pioneers neurological care in India and beyond, boasting advanced facilities and over 180,000 successful neurosurgeries.

Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care

Retrieved on: 
Monday, March 11, 2024
Hospital, Neurology, Radiation, Apollo, Health, Anesthesia, Patient, Neoplasm, Stroke, Stereotactic surgery, Quality of life, Cancer, Apollo Hospitals, Medical imaging

ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.

Key Points: 
  • ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.
  • Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group said, "For four decades, Apollo Hospitals has pioneered healthcare, advancing exceptional care.
  • We pledge to democratize technology, making it accessible to all citizens and global communities, elevating standards of brain tumor treatment and ensuring better quality of life.
  • The Apollo Institute of Neurosciences pioneers neurological care in India and beyond, boasting advanced facilities and over 180,000 successful neurosurgeries.

EQS-News: MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging

Retrieved on: 
Wednesday, March 13, 2024
Acquisition, Pet, Algorithm, Veterinary medicine, Quality of life, 3D, Animal, Radiology, Growth, Veterinarian, Risk, Health, Anesthesia, MIG, Diagnosis, Neurology, Human, MRI, Medical imaging

The funding round is led by MIG Capital, with participation from a French investment bank.

Key Points: 
  • The funding round is led by MIG Capital, with participation from a French investment bank.
  • HawkCell has developed an innovative system incorporating both hardware and software solutions to augment animal MRI imaging.
  • With its one-of-a-kind imaging solutions for veterinarians and pre-clinical research, HawkCell will change how we understand and care for animals.
  • We have been impressed by the highly talented and dedicated team with admirable ambitions to transform the future of animal imaging.

EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend

Retrieved on: 
Wednesday, March 13, 2024
Growth, Safety, Anesthesia, EUR, DVA, Tax, Lithium

Net sales in the safety division even rose by 17.2 percent (net of currency effects) to EUR 1,407.3 million (2022: EUR 1,223.7 million).

Key Points: 
  • Net sales in the safety division even rose by 17.2 percent (net of currency effects) to EUR 1,407.3 million (2022: EUR 1,223.7 million).
  • Earnings development in the 2023 fiscal year was positively impacted in particular by the high net sales growth and improved gross margin.
  • Dräger's net sales increased by 5.1 percent (net of currency effects) to EUR 1,052.6 million (Q4 2022: EUR 1,018.2 million).
  • Against this backdrop, Dräger expects an increase in net sales of 1.0 to 5.0 percent (net of currency effects).

Six Years Strong: Founder of Revitalist Kathryn Walker’s Continuous Leadership in Revolutionizing Mental Health Care

Retrieved on: 
Friday, February 23, 2024
Artificial intelligence, AI, Neuroscience, Intelligence, DSM-IV codes, Telehealth, Ketamine, Pain, Trauma Center, Suicidal ideation, Depression, Anxiety, Trauma, Anesthesia, COVID-19, City, Therapy, Patient, Wellness, PTSD, Science, Statistics, Pharmaceutical industry

The COVID-19 pandemic especially, has exacerbated mental health issues, with increased mood disorders, substance use, and suicidal ideation rates.

Key Points: 
  • The COVID-19 pandemic especially, has exacerbated mental health issues, with increased mood disorders, substance use, and suicidal ideation rates.
  • Kate NeuroPsych represents a groundbreaking approach to mental health care — offering 24/7 availability, personalized recommendations, and worldwide access — being designed by scientific leaders who are positively disrupting healthcare delivery at Revitalist and Sama Therapeutics .
  • Looking ahead, Kathryn envisions a future where psychedelics are normalized as essential tools in mental health care.
  • With each milestone she achieves, Kathryn Walker continues to redefine the boundaries of mental health care and inspire hope for a brighter, more compassionate future.

VAV Enters LatAM with High-Purity Lipids, Eyes 40% Share in Five Years

Retrieved on: 
Thursday, March 7, 2024
Cosmetics, Retail, Health, Research, Science, Pharmaceutical, Biotechnology, ISO, COSMOS, USD, Food safety, Marketing, United States Pharmacopeia, Lecithin, Occupational safety and health, OSHA, Vaccine, API, Anesthesia, VAV, Phospholipid, Liposome, USP, All, Kedia

VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.

Key Points: 
  • VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.
  • The biopharmaceutical company manufactures plant phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids and neutral lipids, APIs and specialty proteins.
  • VAV Lipids will introduce its entire range of products through the company’s distribution network in Latin America.
  • Arun Kedia, Managing Director of VAV Lipids, said, “Our expansion into Latin America will boost our global presence significantly.

Roseman University College of Nursing Launches Doctoral Program for Nurse Anesthetists

Retrieved on: 
Monday, March 4, 2024
Nursing, Education, Health, Hospitals, Surgery, University, Training, BSN, Student, College, Doctor of Philosophy, RN, MSN, MHS, LTC, Conditional sentence, Anesthesiology, Learning, Outline of health sciences, Anesthesia, Council, Certified Registered Nurse Anesthetist, Accreditation, COA

The College of Nursing at Roseman University of Health Sciences today announced its new Doctor of Nursing Practice in Nurse Anesthesia (DNPNA) program to address the national demand for Certified Registered Nurse Anesthetists (CRNAs).

Key Points: 
  • The College of Nursing at Roseman University of Health Sciences today announced its new Doctor of Nursing Practice in Nurse Anesthesia (DNPNA) program to address the national demand for Certified Registered Nurse Anesthetists (CRNAs).
  • The program, approved by the Council on Accreditation of Nurse Anesthesia Educational Programs (COA), is accepting applications for an inaugural class starting in July 2024.
  • “Roseman’s DNPNA students will learn how to administer anesthesia and deliver anesthesia-related services independently and as part of an interprofessional team.
  • “We are delighted to launch this new program to prepare nurses for one of the most in-demand and critical roles in health care,” says Brian Oxhorn, PhD, RN, dean of Roseman University College of Nursing.

Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China

Retrieved on: 
Monday, February 26, 2024
FDA, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, Tardive dyskinesia, Chorea, VMAT2, Metabolism, EVP, Deuterium, Annual report, TEVA, Marketing, Teva, Partnership, HD, Quality of life, Food, Schizophrenia, Neurological disorder, DSM-IV codes, Globalization, Neuro, Prevalence, Happy Mood, Face, Anesthesia, Central nervous system disease, Pivot, Tongue, CNS, Psychiatry, Patient, Pain, Disease, Extremities, Research, Pharmaceutical industry

The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.

Key Points: 
  • The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.
  • “Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee, General Manager of Teva Greater China.
  • Chorea, one of the most striking physical manifestations of Huntington’s disease, is a neurological disorder that causes involuntary, random muscle movements.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd., founded in 1978, is a leading CNS company in China.

Groundbreaking New Procedure for Azoospermic Men Involving Minimally Invasive Sperm Mapping Combined with Extended Sperm Search and Microfreeze Leads to First Pregnancy

Retrieved on: 
Thursday, March 7, 2024
Sperm, FACS, Scrotum, Testosterone, Microdissection, IVF, Freezing, Pregnancy, FNA Mapping, Anesthesia, Patient, Azoospermia, Male, ESSM, Birth control

NEW YORK, March 7, 2024 /PRNewswire-PRWeb/ --Maze Sexual & Reproductive Health has announced the first pregnancy worldwide as a result of a new, minimally invasive procedure. Specifically, sperm are collected via Sperm Mapping, and then searched for and, if found, frozen or used fresh using Extended Sperm Search and Microfreeze (ESSM). They can then be injected into a partner's egg. The combined procedure, called Grid Needle Sperm Extraction and MicroSearch (GN-SEM), will allow some men with no sperm in the ejaculate (azoospermia) the ability to initiate a pregnancy without surgically opening up the testicle.

Key Points: 
  • Specifically, sperm are collected via Sperm Mapping, and then searched for and, if found, frozen or used fresh using Extended Sperm Search and Microfreeze (ESSM).
  • I'm extremely proud of the fact that we have profoundly changed the way we treat azoospermic and cryptospermic men.
  • With men with cryptospermia (very very few sperm in the ejaculate) we have found and frozen sperm in almost 100% of men! ''
  • As of today, Maze has 30 babies born from sperm collected through ESSM, and 97 men whose sperm are stored.